Navigation Links
Berlin Heart Announces Restructuring of Management
Date:7/7/2009

BERLIN, July 7 /PRNewswire/ -- Ulrich Stroeher, Chairman of the Advisory Board of Berlin Heart, today announced that Dr. Johannes Mueller is leaving the general management of the company on 30 September 2009.

Dr. Mueller belongs to the company's founders and is one of the intellectual fathers of the successful ventricular assist device INCOR(R). He will continue to contribute his wealth of experience in this area as coordinator for projects with external cooperation partners. He will further support the company in developing new markets.

Dr. Mueller was a member of the general management from the very beginning when the company was founded as a start-up enterprise with venture capital in 1996. In October 2006 Berlin Heart AG was acquired by Syscore GmbH and the legal structure was changed to GmbH. Today Berlin Heart has 220 employees and is one of the three worldwide leading medical device companies in the area of mechanical heart support.

On 1 October 2009 Dr. Stefan Thamasett will join the general management of Berlin Heart. Dr. Thamasett has more than seven years of experience in clinical cardiology and possesses long-standing experience as head of marketing and sales in well-known medical device companies. He will manage the company together with Dr. Dirk Lauscher, the company's present General Manager.

About Berlin Heart

Berlin Heart is the only company worldwide that develops, produces, and distributes implantable and external ventricular assist devices for patients of every age and body size. The products EXCOR(R) and INCOR(R) provide mechanical support of the heart for patients suffering from severe end-stage heart failure. The ventricular assist device EXCOR(R) Pediatric is used in infants, children, and teenagers and is leading the worldwide market. EXCOR(R) Pediatric is currently under clinical investigation for pediatric patients in USA. All other products are not approved in USA. Further information on the Berlin Heart products is available under: http://www.berlinheart.com

Contact: Linda Buerk Manager Marketing & PR Phone: +49-(0)30-8187-2650 Mobile: +49-(0)173-629-0803 buerk@berlinheart.de


'/>"/>
SOURCE Berlin Heart GmbH
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Charterhouse Group Partners with MTS Health Investors and Highlander Partners to Acquire Chamberlin Edmonds & Associates, Inc., a Leading Provider of Eligibility Services to Hospitals
2. Berlin Heart Receives First Regulatory Approval in North America
3. Drug for cluster headaches may cause heart problems
4. Use of certain lipid measures not more effective in predicting coronary heart disease
5. Restricting Blood Flow May Help Heart Bypass Patients
6. Urban Smog Tough on Young Adults Hearts
7. Stanford study highlights cost-effective method of lowering heart disease risks
8. Vitamin Es lack of heart benefit linked to dosage
9. Drug That Lowers Resting Heart Rate Being Tested
10. Heart Attack Boosts Diabetes Risk
11. Embryonic Stem Cells Repair Human Heart
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... 2016 , ... For many years, Andrew G. Zubinas has accumulated ... beauty of the Lithuanian language and its poetry inspired him in writing ... lyrically explores all aspects of a living, breathing forest where nothing ever stays the ...
(Date:12/5/2016)... Atlanta, GA (PRWEB) , ... ... ... information technology and security executive networking and relationship-marketing firm, announced today that ... for the 2017 Information Security Executive® (ISE®) Central Awards. , Awards include ...
(Date:12/5/2016)... Novato, CA (PRWEB) , ... December 05, 2016 ... ... company, has extended its partnership with leading global lifestyle design firm kathy ireland® ... , Worldwise® and kathy ireland® Worldwide entered into an exclusive licensing agreement three ...
(Date:12/5/2016)... ... December 05, 2016 , ... Progressive ... of L-Citrulline and glutathione to enhance production of nitric oxide (NO). , NitroGenesis ... shown to produce NO twice as effectively and sustains NO blood levels twice ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... announced that the company will provide alerting technology to Central Illinois Health ... awarded $1.7 million in federal funds as the sole sub-recipient participating with ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... LAKE OSWEGO, Ore. , Dec. 5, 2016 /PRNewswire/ ... in the BioInsight clinical study. The study evaluates the ... 2 insertion procedure in an office setting. ... ProMRI ® technology that is placed underneath a ... atrial fibrillation and syncope (fainting). Atrial fibrillation is a ...
(Date:12/5/2016)... and Gateway Health proudly announce a dynamic collaboration that will ... members with specific high risk needs. In an ... of consumers, Wellbridge combines technology and population expertise with a ... daily behaviors and lifestyle. ... , , "Dealing ...
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, ... Sankyo) today announced preliminary safety and efficacy data ... investigational oral selective MDM2 inhibitor, suggesting that DS-3032 ... including relapsed/refractory acute myeloid leukemia (AML) and high-risk ... escalation part of the phase 1 study of DS-3032 ...
Breaking Medicine Technology: